Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of 169.82 billion. The enterprise value is 186.01 billion.

Market Cap	169.82B
Enterprise Value	186.01B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	3.37B
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	28.49%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 10.55 and the forward PE ratio is 11.70.

PE Ratio	10.55
Forward PE	11.70
PS Ratio	3.50
PB Ratio	5.57
P/TBV Ratio	16.88
P/FCF Ratio	18.32
P/OCF Ratio	9.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.71, with an EV/FCF ratio of 20.07.

EV / Earnings	11.55
EV / Sales	3.87
EV / EBITDA	7.71
EV / EBIT	8.50
EV / FCF	20.07

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.

Current Ratio	0.80
Quick Ratio	0.54
Debt / Equity	0.67
Debt / EBITDA	0.85
Debt / FCF	2.22
Interest Coverage	33.42

Financial Efficiency

Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 41.13%.

Return on Equity (ROE)	60.70%
Return on Assets (ROA)	17.43%
Return on Invested Capital (ROIC)	41.13%
Return on Capital Employed (ROCE)	42.97%
Weighted Average Cost of Capital (WACC)	6.04%
Revenue Per Employee	702,650
Profits Per Employee	232,881
Employee Count	69,505
Asset Turnover	0.61
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 4.42 billion in taxes.

Income Tax	4.42B
Effective Tax Rate	21.53%

Stock Price Statistics

The stock price has decreased by -58.95% in the last 52 weeks. The beta is 0.40, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-58.95%
50-Day Moving Average	51.87
200-Day Moving Average	56.79
Relative Strength Index (RSI)	26.59
Average Volume (20 Days)	273,743

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of 48.59 billion and earned 16.10 billion in profits. Earnings per share was 3.62.

Revenue	48.59B
Gross Profit	40.04B
Operating Income	22.11B
Pretax Income	20.52B
Net Income	16.10B
EBITDA	24.10B
EBIT	22.11B
Earnings Per Share (EPS)	3.62

Full Income Statement

Balance Sheet

The company has 4.24 billion in cash and 20.59 billion in debt, giving a net cash position of -16.35 billion.

Cash & Cash Equivalents	4.24B
Total Debt	20.59B
Net Cash	-16.35B
Net Cash Per Share	n/a
Equity (Book Value)	30.51B
Book Value Per Share	6.86
Working Capital	-6.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.72 billion and capital expenditures -9.45 billion, giving a free cash flow of 9.27 billion.

Operating Cash Flow	18.72B
Capital Expenditures	-9.45B
Free Cash Flow	9.27B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 82.41%, with operating and profit margins of 45.50% and 33.14%.

Gross Margin	82.41%
Operating Margin	45.50%
Pretax Margin	42.24%
Profit Margin	33.14%
EBITDA Margin	49.60%
EBIT Margin	45.50%
FCF Margin	19.08%

Dividends & Yields

This stock pays an annual dividend of 1.66, which amounts to a dividend yield of 4.47%.

Dividend Per Share	1.66
Dividend Yield	4.47%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	50.53%
Buyback Yield	0.34%
Shareholder Yield	4.82%
Earnings Yield	9.48%
FCF Yield	5.46%

Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 5.15 and a Piotroski F-Score of 5.

Altman Z-Score	5.15
Piotroski F-Score	5